Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2023-10-23 00:00:00 ET · period of report 2023-10-19 · accession 0001104659-23-110803 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-10-23 | 2023-10-19 | PTGX | Gupta Suneel | Chief Development Off | M - OptEx | $7.38 | +20.0K | 168.3K | +13% | +$147.6K |
| D | 2023-10-23 | 2023-10-19 | PTGX | Gupta Suneel | Chief Development Off | M - OptEx | $0.00 | -20.0K | 50.0K | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-19 | M | A | 20,000 | $7.38 | 168,317 | D | — | — | (F1) Includes an aggregate of 280 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 9, 2023. |
| 2 | Derivative | Stock Option (right to buy) | 2023-10-19 | M | D | 20,000 | $0.00 | 50,000 | D | $7.38 · — to 2029-01-14 | 20,000 Common Stock | (F2) These stock options are fully vested. |